Show results for
Refine by
Oncology Software In Europe
38 software items found
Manufactured by:Elekta Instrument AB based inStockholm, SWEDEN
Efficient care management for radiation oncology. Keep care teams informed and work flowing smoothly with an integrated information system. Elekta Care Management software helps you efficiently manage all aspects of your radiation oncology program. With MOSAIQ Radiation Oncology, all patient information is collected and accessible, from diagnosis ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Sensitive novel fusion detection optimized for small lung cancer FFPE biopsies enhance patient care. SOPHiA DDM™ Dx RNAtarget Oncology Solution (ROS) is a CE-marked in vitro diagnostic (IVD) application based on next-generation sequencing (NGS) enabling accurate and sensitive detection of novel (partner-agnostic) fusions and exon skipping events, even with minimal RNA ...
by:Intrasense based inMontpellier, FRANCE
Myrian® XP-Prostate is an application dedicated to the visualization and analysis of prostate magnetic resonance ...
by:Intrasense based inMontpellier, FRANCE
Myrian® XP-Colon workstation is used to visualize CT Colonography (CTC) images - prone and supine acquisitions - in both 2D and 3D modes. This workstation provides a range of features and tools dedicated to colon exploration, report generation and DICOM ...
by:Intrasense based inMontpellier, FRANCE
Myrian® XP-Liver is an application dedicated to the visualization and analysis of injected liver ...
by:Olea Medical based inLa Ciotat, FRANCE
Our advanced oncology MRI imaging software solution provides a better understanding of the pathology and improves communication across the different medical specialties for better patient care. ...
by:Intrasense based inMontpellier, FRANCE
Myrian® XP-Abdofat is a non-invasive post processing application dedicated to the automatic segmentation and quantification of the abdominal ...
by:Intrasense based inMontpellier, FRANCE
The Myrian® XP-Oncology module is designed for longitudinal follow-up of diagnosed tumor lesions. ...
by:Portable Medical Technology Ltd. based inKillarney, IRELAND
ONCOassist is the go-to app for oncology and haematology professionals. It offers easy access to relevant, up-to-date tools and content when and where it is needed. With the advent of genomic sequencing, combined with an aging population, and new therapies. The decision-making process for oncology/haematology HCP’s is becoming increasingly complex. ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Hematological tumors represent the fourth most frequent cancer type in the developed world. In addition to the continuously evolving clinical guidelines2, harnessing of all the available information when investigating hematological disorders into meaningful insights can be outdated, inaccurate, costly, and time-consuming. This ultimately risks limiting researchers’ productivity, thus ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Hereditary causes account for ∼10% of cancer cases, and an estimated 20% of cancer patients have a family history of cancer. Identification of an individual with a suspected hereditable cancer can lead to additional examinations and help formulate the most appropriate prevention strategies. Evaluating the predisposition to develop inherited cancer depends on the ability to characterize genes ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Genomic profiling is driving precision oncology. From targeted to comprehensive solutions, Next-Generation-Sequencing (NGS) offers the capacity to simultaneously analyze a select set of genes, regions, and biomarkers based on known involvement across solid tumor such as lung, colon, breast, melanoma, gastric, and ovarian cancers. ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Maximize your biologically actionable insights from small tumor samples with the SOPHiA DDM™ RNAtarget Technology end-to-end solutions. Gene fusions have been associated with various tumors and are recognized as valuable cancer biomarkers in cancer research1. Targeted RNA sequencing is recommended to maximize novel fusion detection by identifying transcribed and potentially actionable ...
Manufactured by:Quantum Surgical SAS based inMontpellier, FRANCE
Epione is an open robotic solution compatible with any imaging systems. The medical robot is designed to allow physicians their choice of any ablative technologies (radiofrequency, microwave, cryoablation, irreversible electroporation) so they can decide the right therapy for each individual ...
by:Physiomics Plc based inOxford, UNITED KINGDOM
Virtual Tumour™ is our advanced, predictive modelling simulation tool used worldwide by global pharmaceuticals to small biotech companies to support oncology ...
by:Inspirata, Inc based inTampa, FLORIDA (USA)
NLP-based AI for automated cancer datasets and registry reporting. Inspirata’s E-Path suite of cancer registry automation solutions is powered by an oncology-specific Natural Language Processing (NLP) based artificial intelligence fine-tuned for cancer reporting. While complementing existing workflows, E-Path removes operator variability and far exceeds human performance in ...
by:Indica Labs Inc. based inAlbuquerque, NEW MEXICO (USA)
Indica Labs’ Multiplex IHC module separates up to five stains simultaneously within any cellular compartment (nucleus, cytoplasm or membrane) and can be used for a variety of IHC applications. This module is ideally suited for applications in immuno-oncology where multiple markers are required to characterize distinct immune and tumor cell populations within the tissue. ...
by:Indica Labs Inc. based inAlbuquerque, NEW MEXICO (USA)
With unmatched ease-of-use and scalability, powerful analytic capabilities, and the fastest processing speeds available for digital pathology, pharmaceutical, healthcare and research organizations worldwide are using HALO for high-throughput, quantitative tissue analysis in oncology, neuroscience, metabolism, toxicology and more. ...
by:Indica Labs Inc. based inAlbuquerque, NEW MEXICO (USA)
With the option to define specific cell phenotypes according to marker positivity, this module is ideally suited for applications in immuno-oncology where multiple markers are required to characterize distinct immune and tumor cell populations within the tissue. It can be used in conjunction with most fluorescent whole-slide image formats, multispectral floating-point tiff ...
by:SOPHiA Genetics based inBoston, MASSACHUSETTS (USA)
Powered by state-of-the-art proprietary algorithms, the SOPHiA DDMTM Platform reveals deep genomic insights from cell-free DNA, advancing your oncology research to new ...